(Q40914889)

24 September 2017

1 reference

title

Human parvovirus B19 and blood products (English)

1 reference

24 September 2017

Prowse C

1

1 reference

PubMed ID

9031493

24 September 2017

Ludlam CA

series ordinal

2

1 reference

PubMed ID

9031493

24 September 2017

Yap PL

series ordinal

3

1 reference

24 September 2017

1 January 1997

1 reference

24 September 2017

1 reference

24 September 2017

72

1 reference

24 September 2017

1-10

1 reference

24 September 2017

1

1 reference

Experimental parvoviral infection in humans

24 September 2017

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

The role of parvovirus B19 in aplastic crisis and erythema infectiosum (fifth disease).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Resistance to parvovirus B19 infection due to lack of virus receptor (erythrocyte P antigen).

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Parvovirus B19 infection and hematopoiesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Transmission of serum parvovirus-like virus by clotting-factor concentrates

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Parvovirus B19 infection in patients with hemophilia

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Spectrum of parvovirus B19 infection: analysis of an outbreak of 43 cases in Cadiz, Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

High frequency of parvovirus B19 in patients tested for rheumatoid factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Observational study of effect of intrauterine transfusions on outcome of fetal hydrops after parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): a treatable cause of anemia in AIDS.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Detection of human parvovirus B19-specific IgM and IgG antibodies using a recombinant viral VP1 antigen expressed in insect cells and estimation of time of infection by testing for antibody avidity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Blood donor screening for parvovirus B19.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Eliminating parvovirus B19 from blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Parvovirus B19 and blood products

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Reliability of polymerase chain reaction for detection of hepatitis C virus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

HUMAN PARVOVIRUS ARTHROPATHY

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Candidate recombinant vaccine for human B19 parvovirus

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Parvovirus B19 infection in hospital workers: community or hospital acquisition?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Human parvovirus, the cause of erythema infectiosum (fifth disease)?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Detection of human parvovirus B19 DNA in plasma pools and blood products derived from these pools: implications for efficiency and consistency of removal of B19 DNA during manufacture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Chronic parvovirus B19 infection and systemic necrotising vasculitis: opportunistic infection or aetiological agent?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Management and outcomes of pregnancies complicated by human B19 parvovirus infection: a prospective study

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Fetal pathology in intrauterine death due to parvovirus B19 infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Recurrent granulocytic aplasia as clinical presentation of a persistent parvovirus B19 infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Antibody capture haemadherence tests for parvovirus B19-specific IgM and IgG

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Detection of the human parvovirus B19 in a blood donor plasma in Rio de Janeiro

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

Effect of grapefruit juice on blood cyclosporin concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1423-0410.1997.00001.X

10.1046/J.1423-0410.1997.00001.X

21 January 2018

Identifiers

DOI

1 reference

24 September 2017

1 reference

PubMed ID

9031493